Intel Is Up 220% in 2026. Can It Reach $150 Before 2026 Is Over?

Intel shares have risen more than 220% in 2026, making it the S&P 500's sixth-best performer, but the article argues that the rally already discounts a successful turnaround. Intel's data-center and AI segment grew 59% year over year in Q2, while a reported Apple agreement to use Intel as a secondary supplier could support its foundry recovery. However, Intel trades at 81x current-year and 59x next-year earnings estimates versus TSMC at 26x and 20x, respectively; the article favors TSMC and advises taking Intel gains due to elevated execution and valuation risk.

Analysis

The relevant disconnect is not simply relative valuation: Intel’s equity case requires simultaneous execution across process yields, external-customer qualification, factory utilization, and product competitiveness. Foundry revenue can be announced well before it is economically meaningful; early wafer volume is typically margin-dilutive while qualification, packaging, and yield costs remain elevated. A renewed gross-margin recovery and credible utilization ramp—not additional customer headlines—are the metrics that can support the current multiple over the next 1-3 quarters.

TSMC captures the same AI capital-spending cycle with materially less dependence on a single turnaround path. It also benefits if leading chip designers diversify manufacturing geographically, because diversification generally increases total qualified capacity rather than immediately displacing TSMC’s leading-edge share; its advanced packaging footprint is an additional bottleneck tollbooth. The principal offset is Taiwan geopolitical risk, which can reappear abruptly as a valuation discount independent of operating execution.

The market may be underpricing the lag between a reported design win and recurring foundry earnings. Even a large customer award would likely have limited near-term EPS contribution absent disclosed wafer volumes, node economics, and take-or-pay commitments, while Intel’s capital intensity leaves downside asymmetric if utilization disappoints. Conversely, a confirmed multiyear external-volume commitment combined with gross-margin guidance moving decisively higher would invalidate the relative-short thesis quickly.

Key Decisions for Investors

• Initiate a 6-12 month market-neutral pair: long TSM / short INTC, sized dollar-neutral. Target relative multiple convergence through Intel estimate-risk and TSM advanced-node/packaging earnings resilience; reassess if INTC guides to sustained gross-margin expansion and identifies binding external-volume commitments.
• Do not chase INTC customer-rumor upside. Treat any reported AAPL manufacturing relationship as an alert pending disclosure of node, production timing, wafer volume, and economics; absent those details, it should not be modeled as a material 12-month earnings catalyst.
• For existing INTC longs, reduce exposure into strength or hedge with 3-6 month put spreads rather than selling volatility outright. The catalyst window for negative repricing is the next two earnings reports, when foundry losses, capex, and utilization guidance become harder to defer; risk is a verified marquee-customer announcement or materially stronger AI CPU demand.
• Maintain TSM as the preferred AI-semiconductor manufacturing exposure, but cap position risk around Taiwan-related headlines. A sharp escalation in cross-strait tensions, export-control changes affecting major fabless customers, or evidence that advanced-node demand is normalizing would be the key thesis breaks.